Cystic fibrosis and pseudomonas infection. Lancet1983; 2: 257–8.
2.
BeaudryPHMarksMIMcDougalD, Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?J Pediatr1980; 97: 144–7.
3.
McLauglinFJMatthewsWJStriederDJ, Clinical and bacteriologic responses to three antibiotic regimens for acute exacerbations of cystic fibrosis. Ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo. J Infect Dis1983; 147: 559–67.
McFarlaneHHolzelABrenchleyP, Immune complexes in cystic fibrosis. Br Med J1975; 1: 423–8.
8.
HoibyNFlensborgEWBeckB, Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis1977; 58: 65–79.
9.
ReynoldsHYDi Sant'AgnesePAZierdtCH. Mucoid Pseudomonas aeruginosa: A sign of cystic fibrosis in young adults with chronic pulmonary disease?JAMA1976; 236: 2190–2.
10.
HyattACChippsBEKumorKM, A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis. J Pediatr1981; 99: 307–11.
11.
WientzenRPrestidgeCBKramerRI, Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo therapy. Am J Dis Child1980; 134: 1134–8.